|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 4/22/2019 2:24:33 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1554, Resident Education Deferred Interest (REDI) Act, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, all provisions
H.R. 1520, Purple Book Continuity Act of 2019, all provisions
H.R. 1503, Orange Book Transparency Act of 2019, all provisions
H.R. 1499, Protecting Consumer Access to Generic Drugs Act of 2019, all provisions
H.R. 965, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019, all provisions
H.R. 1425, State Health Care Premium Reduction Act, all provisions
H.R. 1386, Expand Navigators' Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, all provisions
H.R. 986, Protecting Americans with Preexisting Conditions Act of 2019, all provisions
H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, all provisions
H.R. 987, Marketing and Outreach Restoration to Empower (MORE) Health Education Act of 2019, all provisions
H.R. 1010, To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect, all provisions
H.R. 1143, Educating Consumers on the Risks of Short-Term Plans Act of 2019, all provisions
H.R. 8, Bipartisan Background Checks Act of 2019, all provisions
S. 192, Community and Public Health Programs Extension Act, all provisions
H.R. 5977, Mothers and Offspring Mortality and Morbidity Awareness (MOMMAs) Act, all provisions
H.R. 5, Equality Act, all provisions
Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018, all provisions
Affordable Care Act (ACA) implementation
21st Century Cures Act implementation
Surprise billing: Out of network billing for physician services at in-network facilities
Healthcare augmented intelligence
CDC gun violence prevention research funding
Red Flag Laws
Reducing Health Care Costs
Prior authorization and medication-assisted therapy
Electronic Prior Authorization (ePA)
Data privacy
Drug Compounding
Medical marijuana research
Health IT - data blocking, Interoperability, 42 CFR Part 2, HIPAA
Cybersecurity
Open Payments Program/Treatment of peer-reviewed journal articles textbook excerpts
Opioids
Telehealth
Drug Pricing
Software as a medical device (SaMD)
Laboratory developed tests
Electronic Health Records (EHR) certification
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Ashley |
McGlone |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
S. 948, Conrad State 30 and Physician Access Reauthorization Act, all provisions
Conrad 30 Program
Physician Workforce Shortage
H-1B petitions/Cap-subject aliens
Forced feeding of immigrant detainees in U.S. custody
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Competition in health insurance marketplace
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Chase |
Thomas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1781, Payment Commission Data Act of 2019, all provisions
H.R. 1763, Resident Physician Shortage Reduction Act of 2019, all provisions
S. 348, Resident Physician Shortage Reduction Act of 2019, all provisions
H.R. 913, Covering Life-saving Investigations Needed in Cancer and Other Life-threatening Conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today (CLINICAL TREATMENT) Act, all provisions
H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018, all provisions
Medicare program: Remove Extraneous Measures that Obstruct Value and Efficiency (REMOVE) Act, all provisions
Medicare program: Medicare Access and Chip Reauthorization Act (MACRA) implementation
Medicare program: Protecting Access to Medicare Act (PAMA)
Medicare program: 21st Century Cures Act implementation
Medicare program: MACRA burden reduction
Medicare program: Lifting Medicare restrictions on telehealth services
Medicare program: Medicare-for-all legislation
Medicare program: Graduate Medical Education cap flexibility
Medicare program: Alternative Payment Models (APMs)/Physician-Focused Payment Model Technical Advisory Committee (PTAC)
Medicare program: Misvalued codes
Medicare program: Pharmacy Benefit Manager (PBM)/Rx drug price transparency
Medicare program: Cybersecurity
Medicare program: International Pricing Index Model for Medicare Part B Drugs
Medicare program: Advanced APMs - Stark Modernization
Medicare program: Regulatory Relief
Medicare program: Diabetes Prevention Program
Medicare program: Exchange Program Integrity
Medicare program: Merit-based Incentive Payment System (MIPS) - quality, cost, improvement activities, promoting interoperability
Medicare program: MIPS/Total Per Capita Cost (TPCC)
Medicare program: MIPS/physician penalties
Medicare program: Measure harmonization
Medicare program: Modernizing Part D and Medicare Advantage/six protected classes
Medicare program: Drug Pricing
Medicare program: Evaluation and Management guidelines and payment
Medicare program: Health Insurance Portability and Accountability Act (HIPAA)
Medicare program: Da Vinci Project/prior authorization
Medicare program: Health IT/physician burdens
Medicare program: Opioids
Medicare program: Medicare payment issues
Medicare program: CPT Code/eMedicare
Medicare program: Open Payments program
Medicare program: Provider Enrollment, Chain and Ownership System (PECOS)/Medicare enrollment/revocations/revalidations
Medicare program: National Coverage Determination (NCD)/Next Generation Sequencing (NGS) for beneficiaries with advanced cancer
Medicare program: Quality Improvement Organizations (QIO) Manual guidance on redeterminations/alignment with current Agency instructions
Medicare and Medicaid programs: Data Privacy
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), White House Office, Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Ashley |
McGlone |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
VA Maintaining Internal Systems and Strengthening Integrated Outside Networks (VA MISSION) Act of 2018, all provisions
Veterans
Scope of Practice
Veterans Choice/Community Care Program
Tricare
VAs Anywhere to Anywhere Initiative (telehealth)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
BUD |
TAX |
TOB |
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |